NCT03151395 - Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific | Biotech Hunter

Enrollment

197

Participants

Timeline

Start Date

August 25, 2017

Primary Completion Date

April 6, 2020

Study Completion Date

April 6, 2020

Conditions

Respiratory Disorders

Interventions

OTHER

Sputum and blood sampling

Evaluation of the occurrence of potential bacterial and viral pathogens in the sputum of stable COPD patients and at the time of AECOPD.

Trial Locations (19)

100

GSK Investigational Site, Taipei

404

GSK Investigational Site, Taichung

500

GSK Investigational Site, Changhua

1000

GSK Investigational Site, Manila

1014

GSK Investigational Site, Manila

3019

GSK Investigational Site, Marilao, Bulacan

5000

GSK Investigational Site, Iloilo City

GSK Investigational Site, Jaro, Iloilo City

20401

GSK Investigational Site, Keelung

26426

GSK Investigational Site, Gangwon-do

40201

GSK Investigational Site, Taichung

40705

GSK Investigational Site, Taichung

Unknown

GSK Investigational Site, Kowloon

GSK Investigational Site, Lai Chi Kok

GSK Investigational Site, Shatin

420-717

GSK Investigational Site, Bucheon-si

403-720

GSK Investigational Site, Incheon

03312

GSK Investigational Site, Seoul

156-755

GSK Investigational Site, Seoul